Form 4: Novavax Executive James Patrick Kelly Reports Stock Transactions
SEC Form 4 Filing
EVP, CFO, and Treasurer of Novavax, James Patrick Kelly, reports the disposition of common stock and restricted stock units on March 1, 2025.
Summary
- On March 1, 2025, James Patrick Kelly, the EVP, CFO, and Treasurer of Novavax Inc., reported transactions involving Novavax's common stock and Restricted Stock Units (RSUs).
- Kelly disposed of 58,667 shares of common stock related to the vesting of Restricted Stock Units.
- Additionally, Kelly disposed of 28,337 shares of common stock at a price of $8.33.
- Following these transactions, Kelly directly owns 62,932 shares of Novavax common stock and 117,333 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect a broader industry trend but is specific to the individual's transactions and company performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of the reported transactions (disposal of common stock and vesting of Restricted Stock Units). |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.